Adam Knepp developed a novel homogeneous time-resolved fluorescence-based assay using labeled antibodies to quantify CCR5 (chemokine C-C receptor 5).  The technology can be used to screen for conditions favoring receptor stability, which is important for a variety of biochemical and biophysical experiments.